About AbbVie
Source: AbbVie Presentation
AbbVie: Investment Thesis
In the 5 months since the July 18, 2019 date of publication of my article, "Sell Celgene, Buy Bristol-Myers Ahead Of Proposed Merger", the Bristol-Myers share price has increased by 46% from $44.05 to $64.16 today. At the time I wrote, "A detailed analysis suggests a significant increase in Bristol-Myers Squibb adjusted non-GAAP EPS, purely as a result of the combination, and before any savings due synergies." A similar situation exists with the AbbVie (ABBV) acquisition of Allergan (AGN), and just